For research use only. We do not sell to patients.

HBV-IN-12

CAS No. : 2724229-06-3

Biological Activity：HBV-IN-12 is a potent hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC₅₀ ≤0.05 μM). HBV-IN-12 shows anti-HBV DNA activity (0.001 μM＜EC₅₀ ≤0.02 μM). From patent WO2021204252A1, compound 15.

Research Area：Infection

Targets：HBV

Related Small Molecules:DVR-01;Bicyclol;Catalpol;Schisantherin C;HBV-IN-20;Glycosmisic acid;Schisanwilsonin C;RO6889678;Thiamine hydrochloride;Evixapodlin;Canocapavir;HBV-IN-19;Bifendate-d6;(5S,8R)-HBV-IN-10;Punicalin;OSS_128167;3′-DMTr-dG(iBu);HBV-IN-8;HBV-IN-7;L-2′-Fd4C;AB-729;Hepatitis B Virus Core (128-140);Besifovir Dipivoxil maleate;AT-130;HBV-IN-4

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

About Us:

• MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
• Structurally and synthetically diverse biologically active compounds；
•  roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
• We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
• Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；

Structurally and synthetically diverse biologically active compounds；

• Customized order volume ranging from milligrams to kilograms scale；

We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.